In September 2019, Lisa M. Mandrusiak came 4th as the contributor most read in United States with the article Thinking Outside The (Utility Patent) Box - Don't Overlook Design Patent Protection In The Life Sciences via the Mondaq distribution network.
Oblon obtained a favorable claim-construction result for its client, Ajinomoto Co., in the U.S. District Court for the District of Delaware. The underlying opinion determined that patent claims asserted by Kyowa Hakko Bio against Ajinomoto are indefinite.
Eric W. Schweibenz, Chair of Oblon's ITC Practice Group, will participate in a Knowledge Group webinar on October 22 from 12-2pm EST. The title of the program is "Section 337 Investigations at the ITC: An In-Depth Look at the Recent Trends and Court Rulings."
Several Oblon attorneys will be attending the 2019 AIPLA Annual Meeting on October 24-26th at the Gaylord National Resort & Convention Center.
Oblon is a sponsor of the SEBIO Investor & Partnering Forum 2019 that will be held on November 6-7th at The Biltmore in Miami-Coral Gables, Florida. The conference provides an unparalleled opportunity to meet key decision makers in the regional and national life science and medical technology communities. More than 300 biotech and medtech investors, corporate executives, university representatives, and entrepreneurs will attend this year.
Oblon professionals took International Guests to a Nationals baseball game at Nats Park in Washington, DC.
Eleven Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.
Today, Oblon launched its Life Sciences blog, www.lifesciencesipblog.com , which is designed to report and comment on Intellectual property matters related to the life sciences industry.